You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Hims & Hers is expanding into Europe in a global push the company previewed earlier this year.
Hims & Hers (HIMS 6.96%) is using some of its recent $1 billion capital raise to buy ZAVA, a European healthcare company. In this video, Travis Hoium explains why this will keep the company's revenue growing at an incredible pace.
*Stock prices used were end-of-day prices of June 3, 2025. The video was published on June 4, 2025.
Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool's board of directors. Randi Zuckerberg, a former director of market development and spokeswoman for Facebook and sister to Meta Platforms CEO Mark Zuckerberg, is a member of The Motley Fool's board of directors. Travis Hoium has positions in Alphabet and Hims & Hers Health. The Motley Fool has positions in and recommends Alphabet, Hims & Hers Health, and Meta Platforms. The Motley Fool has a disclosure policy. Travis Hoium is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through their link, they will earn some extra money that supports their channel. Their opinions remain their own and are unaffected by The Motley Fool.
Stocks Mentioned
*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.
Related Articles
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
